Objective: This cross-sectional study aimed to evaluate key hepatic cellular markers and systemic inflammatory responses among HBV-infected patients attending outpatient clinics and admitted to inpatient wards at Merjan Teaching Hospital in Babylon Province, Iraq. Method: Serum levels of liver transaminases—alanine aminotransferase (ALT) and aspartate aminotransferase (AST)—were quantitatively measured alongside pro-inflammatory cytokines, specifically Interleukin-6 (IL-6) and Tumor Necrosis Factor-alpha (TNF-α), using Enzyme-Linked Immunosorbent Assay (ELISA) techniques, and compared against healthy controls. Results: Statistically significant elevations (p ≤ 0.01 for liver enzymes; p ≤ 0.001 for cytokines) were observed in HBV patients compared to the control group. Novelty: These findings demonstrate that continuous immune-mediated hepatocyte destruction and cytokine dysregulation drive the pathogenesis of HBV, underlining the clinical relevance of incorporating cytokine profiling alongside standard liver function tests for improved diagnostic and prognostic monitoring.
Copyrights © 2026